Industry Outlook

Lignocaine is also known as Lidocaine or xylocaine, it is medication used for numbing (as local anesthetic) a particular area during surgical procedures. Use of Lignocaine along with small amount of adrenaline for increasing the span of numbing & to reduce the bleeding. Lignocaine is used in the form of injection, but sometimes it is also applied directly to mucous membrane or skin to numb the part. Lignocaine is a part of World Health Organization's List of Essential Medicines, as a safe & effective medicine in health sector. It is cost-effective & generic medication. Lignocaine also used as a cough suppressor in inhalation form. Therefore, the Lignocaine Market is anticipated to expand and has tremendous scope during the forecast period. The global Lignocaine Market anticipated to flourish in the future by growing at a significantly higher CAGR.

Market Segmentation

The global Lignocaine Market is based on segment, by Formulation the market is segmented into Inhalation, Injectable and Topical, by Application the market is segmented into Anti-Arrhythmic and Local Anesthesia, and by End User the market is segmented into Academia & Research Institutes, Hospitals & Clinics and Dentist.


Lignocaine Market, By Formulation

Inhalation
Injectable
Topical

Lignocaine Market, By Application

Anti-Arrhythmic
Local Anesthesia

Lignocaine Market, By End User

Academia & Research Institutes
Hospitals & Clinics
Dentist


Regional Insights

On a global front, the Lignocaine Market covers North America (United States, Canada and Mexico), Europe (Germany, UK, France, Russia, Italy, Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific), South America (Brazil, Argentina, Columbia, Rest of South America) and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA).

Lignocaine Market, By Region




North America


U.S.
Canada
Mexico

Europe


Germany
UK
France
Russia
Italy
Rest of Europe

Asia-Pacific


China
Japan
South Korea
India
Southeast Asia
Rest of Asia-Pacific

South America


Brazil
Argentina
Columbia
Rest of South America

Middle East and Africa


Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Rest of MEA


Competitive Analysis

The leading players in the market are Galen US Inc., Endo International, Swati Spentose Pvt. Ltd., Croma-Pharma GmbH, Iwaki Seiyaku Co. Ltd., Sambria Pharmaceuticals, Harman Finochem Limited, Cironpharma, Endo Pharmaceuticals, Mahendra Chemicals, ESBA Laboratories, Pierrel S.p.A. and Sigma-Aldrich. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.


Galen US Inc.
Endo International
Swati Spentose Pvt. Ltd.
Croma-Pharma GmbH
Iwaki Seiyaku Co. Ltd.
Sambria Pharmaceuticals
Harman Finochem Limited
Cironpharma, Endo Pharmaceuticals
Mahendra Chemicals
ESBA Laboratories
Pierrel S.p.A.
Sigma-Aldrich


Some of the key questions answered by the report are:


What was the market size in 2014 and forecast from 2015 to 2025?
What will be the industry market growth from 2015 to 2025?
What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
What are the major segments leading the market growth and why?
Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?